Dr. Harry Stylli – Molecular Technologies Innovator

Over the course of his career, healthcare investor and entrepreneur Dr. Harry Stylli has provided executive leadership to numerous innovative companies. Dr. Harry Stylli currently serves as chairman of OncoCellMDx, a privately held diagnostic testing developer. Using technologies created internally and licensed through Harvard Medical School, the company has created non-invasive blood-based tests to evaluate a cancer’s grade and level of aggression..  Continue Reading.

Latest News

Research

Genes

Genomics

Everything You Need to Know about the 100,000 Genomes Project

The 100,000 Genomes Project is a British initiative led by the National Health Service (NHS). In this article we explore the project’s main aims and how data gathered could increase our scientific understanding of a wide range of diseases, from rare genetic disorders to cancer. What is the aim of the 100,000 Genomes Project? The… Continue Reading